The activated and effector status of NK cells has been also confirmed in BALF as GZMB, GZMA, PRF1, HAVCR2 (Tim-3), and CCL4 are upregulated in COVID-19 patients compared to controls (36). This evidence concerns the gene CCL4 and COVID-19.